zohydro
Marijuana Shows Promise For MS Treatment
I It might be time for you to start explaining marijuana as “a harmful, addictive, opiate based killer that ruins lives.” The concept has labored well for legal opiate based pain relievers. Citing marijuana’s actual medical qualities has been doing little to pressure the federal government to do something. But new pain relievers, like the terrifying Zohydro, easily obtain the …continue reading through
Marijuana Shows Great Potential in Dealing with MS
It might be time for you to start explaining marijuana as “a harmful, addictive, opiate based killer that ruins lives.” The concept has labored well for legal opiate based pain relievers. Citing marijuana’s actual medical qualities has been doing little to pressure the federal government to do something. But new pain relievers, like the terrifying Zohydro, easily obtain the eco-friendly light in the Food and drug administration despite alerts from leaders within the medical area. Even as patient recommendations and clinical research flows in highlighting the positive impact of medicinal marijuana, we’re stuck waiting around the federal government bodies meet up with the relaxation from the electorate.
A week ago, the American Academy of Neurology launched new recommendations regarding the management of ms. MS could be debilitating and effective remedies have alluded doctors for a long time. With the possible lack of consistent effectiveness around the party from the traditional remedies, many patients happen to be made to seek complementary and alternative medications (CAM). There’s formerly not been much when it comes to research concentrating on the prosperity of CAM remedies, until lately. The American Academy of Neurology is finally searching to alter that. They lately launched their findings with different overview of 291 studies and research which involve CAM remedies for MS patients.
Lead author from the review and clinical director of Or Health insurance and Science University’s Ms Center, Dr. Vijayshree Yadav, stated “This may be the first review, evidence-based recommendation, on treating MS with CAM treatments.” He continued to state “there were 29 different treatments incorporated within the recommendations. 19 studies checked out cannabis.” The types of cannabis intake analyzed, however, were using dental cannabis extract and artificial THC. Scientists discovered that these remedies were good at treating discomfort for approximately twelve months, but didn’t address the tremors frequently connected with MS.
Losing effectiveness continues to be credited with other conditions given synthetic marijuana. Patients who’ve used medications for example Sativex have regularly reported benefits that rapidly dissipate. When we would inject good sense as it were, it appears an all natural type of Sativex, say naturally growing marijuana, would without doubt be safer on our bodies. MS scientists don’t have many details on using actual marijuana because they are mostly avoided by federal law to review real cannabis. This research is among many read about this highlights the advantages of marijuana. It really makes a person question if our chosen authorities are reading through, or if they’re even literate.
 
Marijuana Remains Illegal as the Federal Government…
Approves a terrifying new opiate based medication.
The federal government maintains that there are no known medical benefits to marijuana. The actual evidence tells a different story as the FDA continues to choose financial bliss for big pharma over the safety of Americans. While opiates (one of the main components of heroin) are highly addictive, both physically and mentally, they enjoy more legally friendly status when compared to marijuana. Medications such as Oxycontin and Vicodin are costing America in both lives and tax dollars. Emergency room visits related to overdoses cost billions per year, a bill that is picked up by working Americans. The situation has become a known epidemic, with medical leaders calling for action. Even the White House considers the current situation a pandemic. This would lead one to believe that the FDA would never approve newer and more dangerous opiate based medications. That would be false. The FDA has recently approved Zohydro, a more potent opiate based pain killer. CNN described this as “frightening” and Dr. Andrew Kolodny, president of the advocacy group Physicians for Responsible Opioid Prescribing said “It’s a whopping dose of hydrocodone packed in an easy-to-crush capsule…It will kill people as soon as it’s released.” The FDA, of course, responds by saying the medical benefits outweigh the risks. Of course marijuana’s virtually zero mortality rate could make a better argument for the “benefit outweighing the risk” argument. Zohydro is said to be fives times more powerful than Vicodin.
Does not approve more funding for marijuana’s potential to treat Alzheimer’s.
Alzheimer’s impacts the lives of approximately 5.1 million Americans. Since the symptoms can come on gradually, the disease can remain undetected for sometime. This makes calculating definitive numbers difficult. This condition cuts the quality of life short for many who physically are fine, but mentally suffer from dementia. Gary Wenk, a longtime Alzheimer’s researcher has noticed a trend, especially as those who smoked marijuana in the 1960s are now at the vulnerable age. “We found out that people who smoked dope in the 1960s were not getting Alzheimer’s.” While his research is promising, it has unfortunately been brought to a halt. He recently said “I am not funded to do marijuana research…It costed me about $100,000 to do a whole experiment, $10,000 just to buy the molecule and every old rat is $150. You can see how things add up and individuals can’t afford these things.” It appears that their may be some promise for cananbinoids treating and preventing Alzheimer’s, but no one can be certain since the federal government will not open the door for more testing and research. Besides the obvious financial benefits to reforming marijuana laws (marijuana.net has spoken about incarcerations, tax revenues, war on drugs, etc.) Mr. Wenk pointed out that money could be saved in medical treatment. “If we can keep a person out of a nursing home for five years, we’ve saved that family and their insurance companies an awful lot of money… No matter how we spin this, old people are going to win.”
New Prescription Painkiller stated to become Ten Occasions More Effective than Vicotin
America’s growing prescription abuse problem continues to be well recorded. With major news shops for example CNN confirming spikes in infants being born hooked on prescription medications, or Fox News confirming more people die every year from prescription drugs than heroin and cocaine combined, you might assume the Food and drug administration could be thinking about a moratorium on approving more recent and much more potent pills.
Obviously this kind of assumption wouldn’t be consistent with recent reviews that describe the brand new drug Zohydro, that is presently getting used in clinical tests. Zohydro, to be precise, may be the title provided to the drug through the North Park based company Zogenix. Three others (Purdue Pharma, Cephalon, and Egalet) also provide began clinical tests while using potent pure type of hydrocodone but appear to become farther from reaching the marketplace. Based on reviews, Zohydro is 10 occasions as strong as Vicodin, which already costs the American public over 484 billion dollars yearly because of health care costs, incarceration and traffic accidents.
Using the prescription abuse cases already rising by 430% throughout the final 10 years, an herbal viagra with the strength of Zohydro is frightening many experts. The leader from the National Coalition Against Prescription Substance Abuse, April Rovero, told the Connected Press that “”I’ve got a large concern that this may be the following OxyContin” and “We simply have no need for this available on the market.Inch Information provided through the Drug Enforcement Administration established that appointments with the er because of hydrocodone use skyrocketed from 19,221 in 2000 to 86,258 in ’09. This really is clearly before Zohydro hits the marketplace, which will be the first drug to make use of hydrocodone in the pure and many potent form. Hydrocodone is part of the opiate family including methadone, heroin, morphine and oxycodone.
News of Zohydro is baffling for a lot of advocates of medicinal marijuana. Certainly the chance of prescription narcotic abuse is much more than well-established but patients have to legally depend on very potentially addictive substances. Medical cannabis advocates could be skeptical why this type of product could be available. Although people for example Karsten Lindhardt, leader of Egalet, believe that hydrocodone is essential for doctors, most are questioning such motives. The Denmark based Egalet is presently testing their very own pure hydrocodone product. Lindhardt stated “Sometimes you circulate someone between various opioids, plus some could have a better effect than the others,Inch while Jackson, co-founding father of Advocates for that Reform of Prescription Opioids feels “The entire supply-side system is to establish to perpetuate this massive unloading of opioid drugs around the American public.” The thought of circulating opium based items, as Lindhardt indicates, might not sit well with lots of patients.
 
Marijuana.internet will give you ongoing updates on the introduction of the hydrocodone items.